Tenon Medical, Inc. (TNON) Form 8-K — Oct 22, 2026
Tenon Medical entered into a waiver with institutional investor Armistice Capital Master Fund on October 16, 2026, clearing restrictions under their August 2026 purchase agreement so the company can increase the size of its at-the-market equity offering with A.G.P./Alliance Global Partners. As consideration for the waiver, Tenon issued Armistice a Series B warrant for 125,000 shares at a $5.02 exercise price, expiring September 14, 2031, and agreed to file a resale registration statement for the underlying shares within 60 days. The Section 4.12 lockout restrictions were also extended by 15 days to 75 days post-Effective Date.
Key figures
- Atm minimum size
- $4,000,000+
- New warrant shares
- 125000
- Warrant expiration
- September 14, 2031
- Warrant exercise price
- $5.02
- Restriction extension days
- 15
- Resale registration deadline
- within 60 calendar days of waiver
- Registration effectiveness target
- 90 days (120 days if full SEC review)
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.